Breaking News, Collaborations & Alliances

MilliporeSigma to Develop Next-Gen Purification Processes with Int’l Vaccine Inst.

Collaboration to improve manufacturing processes to deliver higher purity vaccines

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

MilliporeSigma has entered a research agreement with the International Vaccine Institute (IVI) of Seoul, South Korea to help develop more robust, scalable vaccine manufacturing processes. MilliporeSigma will provide funding and expertise in the areas of clarification and purification. The IVI is a nonprofit international organization committed to the discovery, development and delivery of safe, effective and affordable vaccines for global public health. The new collaboration between Millipore...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters